Biktarvy, formally known as biktarvy, represents a effective single-tablet therapy for controlling HIV infection. This formula combines three crucial antiviral components: bictegravir, emtricitabine, and tenofovir alafenamide. It operates by inhibiting the virus's ability to copy within the body, considerably lowering the viral quantity. For many